Skip to main content
Log in

Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This study was conducted in order to investigate the level of amitriptyline (AT) and its metabolites. Three separate experiments were carried out. In two of these experiments, rats were treated over 7 days with IP doses of AT (10 mg/kg in experiment A and 2×20 mg/kg in experiment C). The rats were sacrificed either 2 (experiment C) or 12h (experiments A and C) after the last dose. In experiment B, rats were sacrificed 2 or 12 h after a single dose of 20 mg/kg AT.

The results of these experiments showed the following: in experiment A only AT was measurable in the brain and in the plasma, in contrast to experiments B and C, where NT and the hydroxylated metabolites AT-OH and NT-OH reached significant levels in the plasma and in the brain. The concentrations of AT-OH, NT-OH, and NT (12-h values) that were found in the brain are probably not pharmacologically relevant. The 12-h plasma values of all compounds tested were, even with the highest dose, lower than those expected to be clinically effective in man.

Our results suggest that AT, at higher doses, may induce its own metabolism. The free plasma levels of this drug and its metabolites are higher in man than in the rat.

The possible implications of these results in the use of antidepressants in the treatment of depression are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Antelman SM, Chiodo LA (1981) Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis. Biol Psychiatr 16:717–727

    Google Scholar 

  • Antelman SM, DeGiovanni LA, Kocan D, Perel JM, Chiodo LA (1983) Amitriptyline sensitization of a serotonin-mediated behavior depends on the passage of time and not repeated treatment. Life Sci 33:1727–1730

    Google Scholar 

  • Baumann P, Koeb L, Tinguely D, Rivier L (1982) A method for the analysis of free, total plasma and saliva amitriptyline and nortriptyline by dialysis and gc/ms. Eur J Mass Spec Biochem Med Environ Res 2:19–26

    Google Scholar 

  • Baumann P, Tinguely D, Schöpf J, Koeb L, Perey M, Michel L, Balant A, Dick B (1983a) The fate of amitriptyline and its metabolites, taking into account their binding in plasma. In: Gram LF, Usdin E, Dahl SG, Kragh-Sorensen P, Sjöqvist F, Morselli PL (eds) Clinical pharmacology in psychiatry: bridging the experimental-therapeutic gap. Macmillan, London, pp 227–237

    Google Scholar 

  • Baumann P, Gaillard JM, Perey M, Justafre JC, Le P (1983b) Relationships between brain concentrations of desipramine and paradoxical sleep inhibition in the rat. J Neural Transm 56:105–116

    Google Scholar 

  • Baumann P, Dick B, Koeb L, Perey M, Schöpf J, Tringuely D (1984) Amitriptyline-Metabolismus im depressiven Patienten: Pharmakogenetische Aspekte und Eiweißbindung im Plasma. In: Hopf A, Beckmann H (eds) Forschungen zur Biologischen Psychiatrie. Springer, Berlin, pp 298–305

    Google Scholar 

  • Bertilsson L, Mellström B, Sjöqvist F (1979) Pronounced inhibition of noradrenaline uptake by 10-hydroxy-metabolites of nortriptyline. Life Sci 25:1285–1292

    Google Scholar 

  • Breyer U (1972) Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism. Naunyn-Schmiedebergs Arch Pharmacol 272:277–288

    Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ, Kreuter F, Scharek G, Brinkschulte M, Wiatr R (1982) Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels. Psychopharmacology 76:240–244

    Google Scholar 

  • Cassano GB, Sjöstrand SE, Hansson E (1965a) Distribution of C14-labelled amitriptyline in the cat brain. Psychopharmacology 8:12–22

    Google Scholar 

  • Cassano GB, Sjöstrand SE, Hansson E (1965b) Distribution and fate of C14-amitriptyline in mice and rats. Psychopharmacology 8:1–11

    Google Scholar 

  • Charney DS, Heninger GR, Sternberg DE (1983) Alpha-2 adrenergie receptor sensitivity and the mechanism of action of antidrepressant therapy. The effect of long-term amitriptyline treatment. Br J Psychiatr 142:265–275

    Google Scholar 

  • Chiodo LA, Antelman SM (1980) Tricyclic antidepressants induce subsensitivity of presynaptic dopamine autoreceptors. Eur J Pharmacol 64:203–204

    Google Scholar 

  • Clements-Jewery S, Robson PA (1982) Intact 5HT neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline. Neuropharmacology 21:725–727

    Google Scholar 

  • Daniel W, Adamus A, Melzacka M, Szymura J, Vetulani J (1981) Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages. Naunyn-Schmiedebergs Arch Pharmacol 317:209–213

    Google Scholar 

  • Delini-Stula A, Vassout A (1979) Modulation of dopamine-mediated behavioural responses by antidepressants: effects of single and repeated treatment. Eur J Pharmacol 58:443–451

    Google Scholar 

  • De Montigny C, Aghajanian GK (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303–1306

    Google Scholar 

  • Dumbrille-Ross A, Tang SW, Coscina DV (1982) Lack of effect of raphe lesions on serotonin S2 receptor changes induced by amitriptyline and desmethylimipramine. Psychiatr Res 7:145–151

    Google Scholar 

  • Edelbroek PM, Zitman FG, Schreuder JN, Rooymans HGM, de Wolff FA (1984) Amitriptyline metabolism in relation to antidepressive effect. Clin Pharmacol Ther 35:467–473

    Google Scholar 

  • Eschenhof E von, Rieder J (1969) Untersuchungen über das Schicksal des Antidepressivums Amitriptylin im Organismus der Ratte und des Menschen. Arzneim Forsch 19:957–966

    Google Scholar 

  • Friedman E, Cooper TB (1983) Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. J Pharmacol Exp Ther 225:387–390

    Google Scholar 

  • Garland WA, Muccino RR, Min BH, Cupano J, Fann WE (1979) A method for the determination of amitriptyline and its metabolites nortriptyline, 10-hydroxyamitriptyline, and 10-hydroxynortriptyline in human plasma using stable isotope dilution and gas chromatography-chemical ionization mass spectrometry (GC-CIMS). Clin Pharmacol Ther 25:844–855

    Google Scholar 

  • Glotzbach RK, Preskorn SH (1982) Brain concentrations of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically dosed rats. Psychopharmacology 78:25–27

    Google Scholar 

  • Gram LF, Kragh-Sorensen P (1981) Pharmacokinetics and plasma level/effect relationships of tricyclic antidepressants: an update. In: Usdin E, Dahl SG, Gram LF, Lingjaerde O (eds) Clinical pharmacology in psychiatry. Macmillan, London, pp 241–251

    Google Scholar 

  • Hurst HE, Jarboe CH (1981) Clinical findings, elimination pharmacokinetics, and tissue drug concentrations following a fatal amitriptyline intoxication. Clin Toxicol 18:119–125

    Google Scholar 

  • Hyttel J, Christensen AV, Fjalland B (1980) Neuropharmacologyical properties of amitriptyline, nortriptyline and their metabolites. Acta Pharmacol Toxicol 47:53–57

    Google Scholar 

  • Jørgensen A, Hansen V (1976) Pharmacokinetics of amitriptyline infused intravenously in man. Eur J Clin Pharmacol 10:337–341

    Google Scholar 

  • Jørgensen A, Staehr P (1976) On the biological half-life of amitriptyline. J Pharm Pharmacol 28:62–64

    Google Scholar 

  • Keller HH, Burkard WP, Da Prada M (1980) Dopamine receptor blockade in rat brain after acute and subchronic treatment with tricyclic antidepressants. In: Cattabeni et al. (eds) Long-term effects of neuroleptics. Adv Biochem Psychopharmacol 24:175–179

  • Lehman JP, Fenselau C, Depaulo JR (1983) Quaternary ammonium-linked glucuronides of amitriptyline, imipramine, and chloropromazine. Drug Metab Dispos 11:221–225

    Google Scholar 

  • Maître L, Moser P, Baumann PA, Waldmeier PC (1980) Amine uptake inhibitors: criteria of selectivity. In: Svensson TH, Carlsson A (eds) Biogenic amines and affective disorders. Proc. Symp. London, 18–21 Jan. 1979. Acta Psychiatr Scand (Suppl 61) 280:97–110

  • Menkes DB, Kehne JH, Gallager DW, Aghajanian GK, Davis M (1983a) Functional supersensitivity of CNS al-adrenoreceptors following chronic antidepressant treatment. Life Sci 33:181–188

    Google Scholar 

  • Menkes DB, Rasenick MM, Wheeler MA, Bitensky MW (1983b) Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219:65–67

    Google Scholar 

  • Mishra R, Sulser F (1978) Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system. Psychopharmacology 2:365–370

    Google Scholar 

  • Montgomery SA (1981) Prediction of plasma levels and clinical response in depression. In: Usdin E, Dahl SG, Gram LF, Lingjaerde O (eds) Clinical pharmacology in psychiatry. Macmillan, London, pp 263–271

    Google Scholar 

  • Nobrega JN, Coscina DV (1983) Chronic amitriptyline potentiates feeding induced by intrahypothalamic norepinephrine injections. Life Sci 33:1249–1253

    Google Scholar 

  • O'Malley K, Browning M, Stevenson I, Turnbull MJ (1973) Stimulation of drug metabolism in man by tricyclic antidepressants. Eur J Clin Pharmacol 6:102–103

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980a) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980b) Regulation of serotonin 2 (5-HT2) receptors labeled with (3H) spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther 215:582–587

    Google Scholar 

  • Potter WZ, Muscettola G, Goodwin FK (1979a) Binding of imipramine to plasma protein and to brain tissue: relationship to CSF tricyclic levels in man. Psychopharmacology 63:187–192

    Google Scholar 

  • Potter WZ, Calil HM, Manian AA, Zavadil AP, Goodwin FK (1979b) Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity. Biol Psychiatr 14:601–613

    Google Scholar 

  • Preskorn SH, Hartman BK, Clark HB (1980) Long-term antidepressant treatment: alterations in cerebral capillary permeability. Psychopharmacology 70:1–4

    Google Scholar 

  • Preskorn SH, Glotzbach RK (1982) A liquid chromatographic method for quantitating amitriptyline in brain tissue. Psychopharmacology 78:23–24

    Google Scholar 

  • Robinson DS, Cooper TB, Ravaris CL, Ives JO, Nies A, Bartlett D, Lamborn KR (1979) Plasma tricyclic drug levels in amitriptyline-treated depressed patients. Psychopharmacology 63:223–231

    Google Scholar 

  • Roffman M, Kling MA, Cassens G, Orsulak PJ, Reigle TG, Schildkraut JJ (1977) The effects of acute and chronic administration of tricyclic antidepressants on MHPG-SO4 in rat brain. Psychopharmacol Commun 1:195–206

    Google Scholar 

  • Schneider G, Schneider G, Bickel MH (1969) Über das Auftreten von Desmethylimipramin im Gehirn der Ratte nach Gabe von Imipramin in Abhängigkeit von der Injektionsart. Psychopharmacology 16:156–160

    Google Scholar 

  • Schulz P, Turner-Tamiyasu K, Smith G, Giacomini KM, Blaschke TF (1983) Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther 33:360–366

    Google Scholar 

  • Segawa T, Mizuta T, Normura Y (1979) Modification of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants. Eur J Pharmacol 58:75–83

    Google Scholar 

  • Sellinger-Barnette MM, Mendels J, Frazer A (1980) The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain. Neuropharmacology 19:447–454

    Google Scholar 

  • Serra G, Argiolas A, Klimek V, Fadda F, Gessa GL (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 25:415–424

    Google Scholar 

  • Tang SW, Helmeste DM, Stancer HC (1978) The effect of acute and chronic desipramine and amitriptyline treatment on rat brain total 3-methoxy-4-hydroxyphenylglycol. Naunyn-Schmiedebergs Arch Pharmacol 305:207–211

    Google Scholar 

  • Taylor JE, El-Fakanany E, Richelson ER (1979) Long-term regulation of muscarinic acetylcholine receptors on cultured nerve cells. Life Sci 25:2181–2187

    Google Scholar 

  • Vetulani J, Sulser F (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257:495–496

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baumann, P., Gaillard, J.M., Jonzier-Perey, M. et al. Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology 84, 489–495 (1984). https://doi.org/10.1007/BF00431455

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431455

Key words

Navigation